Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ulisse Biomed Spa
UBMCurrent price
0.88 EUR
+0.008 EUR (+0.91%)
Last closed
0.87 EUR
Company
www.ulissebiomed.com
ISIN
IT0005451213
Sector
Healthcare
Industry
Biotechnology
Exchange
Borsa Italiana
Capitalization
20 446 376 EUR
Yield for 12 month
-46.75 %
1Y
3Y
5Y
10Y
15Y
UBM
Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company's platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy. Address: Via Cavour, 20, Udine, UD, Italy, 33100
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.95 EURP/E ratio
18.4Dividend Yield
–Current Year
+119 083 EUR
Last Year
+139 651 EUR
Current Quarter
+16 281 EUR
Last Quarter
+8 141 EUR
Current Year
-1 510 349 EUR
Last Year
-1 557 933 EUR
Current Quarter
-883 573 EUR
Last Quarter
-256 318 EUR
Key Figures UBM
1 year
3 years
5 years
10 years
EBITDA
-6 382 728 EUR
Operating Margin TTM
PE Ratio
18.4
Return On Assets TTM
-25.89 %
PEG Ratio
–
Return On Equity TTM
-46.78 %
Wall Street Target Price
0.95 EUR
Revenue TTM
424 616 EUR
Book Value
1.14 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2197.7 %
Dividend Yield
–
Gross Profit TTM
-902 629 EUR
Earnings per share
0.05 EUR
Diluted Eps TTM
0.05 EUR
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics UBM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History UBM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation UBM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
18.4
Forward PE
–
Enterprise Value Revenue
355.2639
Price Sales TTM
48.1527
Enterprise Value EBITDA
51.9243
Price Book MRQ
0.8194
Financials UBM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators UBM
For 52 weeks
0.84 EUR
1.97 EUR
50 Day MA
0.96 EUR
Shares Short Prior Month
–
200 Day MA
1.18 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart